Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials-Reference-Cited by-同舟云学术

Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials

Published:2022-12 Issue:12 Volume:3 Page:e912-e921
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Wahid Rahnuma,Mercer Laina D,De Leon Tirza,DeAntonio Rodrigo,Sáez-Llorens Xavier,Macadam Andrew,Chumakov Konstantin,Strating Jeroen,Koel Björn,Konopka-Anstadt Jennifer L,Oberste M Steven,Burns Cara C,Andino Raul,Tritama Erman,Bandyopadhyay Ananda S,Aguirre Gabriela,Rüttimann Ricardo,Gast Chris,Konz John O

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference20 articles.

1. The evolutionary pathway to virulence of an RNA virus;Stern;Cell,2017

2. Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization;Laassri;J Clin Microbiol,2005

3. Molecular aspects of poliovirus pathogenesis;Nomoto;Proc Jpn Acad, Ser B, Phys Biol Sci,2007

4. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture;Macadam;Virology,1992

5. The 5′ noncoding region and virulence of poliovirus vaccine strains;Macadam;Trends Microbiol,1994

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enterovirus A71 2A‐S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines;Journal of Medical Virology;2024-07-31

2. Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia: an observational cohort study;The Lancet Infectious Diseases;2024-04

3. Bioprocess strategies for the efficient production of DNA vaccines;Bioreactor Design Concepts for Viral Vaccine Production;2024

4. Approaches to pandemic prevention – the chromatin vaccine;Frontiers in Immunology;2023-12-08

5. Perspective Chapter: The Most Natural Possible Vaccine Administered in the Most Natural Possible Way - Noninvasive over Injectable Vaccine Delivery Routes;New Topics in Vaccine Development [Working Title];2023-11-14